NDC 62106-7086

MEDULLOSSEINUM

Bone Marrow

MEDULLOSSEINUM is a Oral Granule in the Human Otc Drug category. It is labeled and distributed by Seroyal Usa. The primary component is Oryctolagus Cuniculus Bone.

• Product ID: 62106-7086_1b7e7fd3-9352-1424-e054-00144ff88e88
• NDC: 62106-7086
• Product Type: Human Otc Drug
• Proprietary Name: MEDULLOSSEINUM
• Generic Name: Bone Marrow
• Dosage Form: Granule
• Route of Administration: ORAL
• Marketing Start Date: 2015-07-22
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Seroyal USA
• Substance Name: ORYCTOLAGUS CUNICULUS BONE
• Active Ingredient Strength: 6 [hp_X]/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 62106-7086-4

10 TUBE in 1 CARTON (62106-7086-4) > 140 GRANULE in 1 TUBE

• Marketing Start Date: 2015-07-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62106-7086-4 [62106708604]

MEDULLOSSEINUM GRANULE

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-07-22

Drug Details

Active Ingredients

Ingredient	Strength
ORYCTOLAGUS CUNICULUS BONE	6 [hp_X]/1

OpenFDA Data

• SPL SET ID: 1b7e7fd3-9351-1424-e054-00144ff88e88
• Manufacturer:
  • Seroyal USA
• UNII:
  • GD946P479L